Video Latest - ecancer

Pracinostat and azacitidine for elderly AML

Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

ASH 2016: AML, CLL and leukaemogenesis latest

Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Advances in CLL from ASH 2016

Prof Stephan Stilgenbauer, Prof Clemens-Martin Wendtner, Prof Steven Coutre And Dr Jeffery Jones

5 Dec 2016

Ineligibility required for 'anti-trials': inclusion in studies regardless of fitness

Prof Guillermo Garcia-Manero - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Vosaroxin for relapsed AML: Updates from VALOR

Dr Farhad Ravandi - MD Anderson Cancer Center, Houston, USA

5 Dec 2016

Impact of next-generation sequencing on treatment choice for MDS

Dr Ana Alfonso Pierola - MD Anderson Cancer Center, Houston, USA

4 Dec 2016

Obinutuzumab extends PFS for follicular lymphoma in GALLIUM trial

Dr Andrew Davies - University of Southampton, Southampton, UK

4 Dec 2016

Venetoclax plus cytarabine in elderly AML patients

Dr Andrew Wei - Alfred Hospital, Melbourne, Australia

4 Dec 2016

Intravenous or subcutaenous rituximab for FL in the SABRINA study

Dr Andrew Davies - University of Southampton, Southampton, UK

4 Dec 2016

Ibrutinib in CLL: RESONATE and resistance

Dr Jennifer Woyach - The Ohio State University Medical Center, Columbus, USA

4 Dec 2016

Large granular lymphocyte proliferations in MDS

Dr Christa Roe - H. Lee Moffitt Cancer Center, Tampa, USA

4 Dec 2016

Durable remissions with the VcR-CVAD regimen for MCL regardless of age

Dr Julie Chang - University of Wisconsin Hospital and Clinics, Madison, USA

4 Dec 2016

Video